Pediatrix Medical Group, INC Form 4 insider transactions

Director Laura Linynsky reported the acquisition of 11,427 shares of Pediatrix Medical Group, Inc. common stock on May 8, 2025, as part of an annual equity award.

Director Thomas McEachin acquired 11,427 shares of Pediatrix Medical Group stock on May 8, 2025, as part of an annual equity award.

Director Michael A. Rucker reports acquisition of 11,427 shares of Pediatrix Medical Group, Inc. restricted stock as part of an annual equity award.

Director Shirley A. Weis reports acquisition and disposal of Pediatrix Medical Group, Inc. stock, including restricted shares granted under the company's incentive plan.

Director Guy P. Sansone acquired 11,427 shares of Pediatrix Medical Group, Inc. common stock as part of the company's Amended and Restated 2008 Incentive Compensation Plan.

Director John M. Starcher Jr. reports changes in beneficial ownership of Pediatrix Medical Group, Inc. common stock, including acquisition of shares and disposal of shares.

Mary Ann E. Moore, EVP, GC, Chief Admin Off & Sec of Pediatrix Medical Group, transferred 26,497 shares of common stock to a family trust on March 6, 2025.

Kasandra H. Rossi, EVP, CFO and Treasurer of Pediatrix Medical Group, Inc., reports the disposition of 3,718 common stock shares to cover tax obligations upon vesting.

Mary Ann E. Moore, EVP, GC, Chief Admin Off & Sec of Pediatrix Medical Group, reports a transaction involving common stock on March 1, 2025.

Director Shirley Weis transferred 17,668 shares of Pediatrix Medical Group, Inc. common stock to a family trust on February 25, 2025.

Mark S. Ordan, CEO of Pediatrix Medical Group, acquired 640,000 performance share units (PSUs) on January 12, 2025, which will vest based on service and stock price performance.

Kasandra H. Rossi, EVP, CFO and Treasurer of Pediatrix Medical Group, Inc., received 11,112 shares of restricted stock as part of an annual equity award.

A director of Pediatrix Medical Group, Mark S. Ordan, sold 27,600 shares of common stock at a weighted average price of $15.35.

Mary Ann E. Moore, an executive at Pediatrix Medical Group, sold 8,108 shares of common stock at an average price of $16.00 per share.

James D. Swift, CEO of Pediatrix Medical Group, sold 11,100 shares of common stock at an average price of $10.79 on August 30, 2024.

Director Laura Linynsky sold 7,000 shares of Pediatrix Medical Group, Inc. (MD) common stock on August 27, 2024, at a weighted average price of $11.16 per share.

C. Marc Richards, EVP and CFO of Pediatrix Medical Group, sold a total of 50,000 shares of common stock in two transactions on August 9 and August 12, 2024.

CEO James D. Swift reports acquisition of restricted shares and disposal of common stock on June 1, 2024.

EVP and Chief Operating Officer of Pediatrix Medical Group, Curtis Pickert, reports acquisition and disposal of company shares, including a grant of restricted stock and a transfer to a family trust.

C Marc Richards, EVP and CFO of Pediatrix Medical Group, reports the acquisition of restricted shares as part of an annual equity award.

EVP Lee Wood reports acquisition of restricted shares and disposal for tax obligations related to vesting shares.

Mary Ann E. Moore, EVP, General Counsel & Secretary of Pediatrix Medical Group, Inc., reports acquisition of shares through the company's incentive plan.

Director John M. Starcher Jr. reported acquiring shares of Pediatrix Medical Group, Inc. on May 9, 2024.

Director Sylvia Young received a grant of 18,360 shares of Pediatrix Medical Group common stock and disposed of 29,191 shares on May 9, 2024.

Director Shirley A. Weis reports acquiring and disposing of Pediatrix Medical Group, Inc. common stock on May 9, 2024, according to a Form 4 filing with the SEC.

Director Laura Linynsky reported the acquisition of 18,360 shares of Pediatrix Medical Group, Inc. common stock on May 9, 2024, as part of an annual equity award.

Director Michael A. Rucker reports acquisition of 18,360 restricted shares of Pediatrix Medical Group, Inc. as part of an annual equity award.

Director Thomas McEachin received 18,360 shares of Pediatrix Medical Group stock on May 9, 2024, as part of an annual equity award.

Director Guy P Sansone acquired 18,360 shares of Pediatrix Medical Group, Inc. common stock on May 9, 2024, as part of the company's incentive compensation plan.

Director Mark S. Ordan reported acquiring 18,360 shares of Pediatrix Medical Group, Inc. common stock on May 9, 2024, as part of an annual equity award.